US

Matthew David Surman

This inventor holds 0 USPTO granted patents, plus 3 CIPO patents.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Matthew David Surman. Retrieved from https://idiyas.com/inventor/matthew-david-surman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
 

Average Co-Inventor Count = 1.0

ph-index = 1


Loading Chart...

Title: Matthew David Surman: Innovator in Pharmaceutical Chemistry

Introduction

Matthew David Surman is a notable inventor in the field of pharmaceutical chemistry. He has made significant contributions to the development of substituted pyridoindoles, which are utilized in the treatment of various diseases. His innovative work has the potential to impact the pharmaceutical industry positively.

Latest Patents

Matthew David Surman holds a patent for "1-Azinone-Substituted Pyridoindoles As Mch Antagonists." This patent describes substituted pyridoindoles for incorporation in pharmaceutical compositions. The compounds correspond to a specific formula, wherein various substituents are defined, allowing for a range of applications in medical treatments.

Career Highlights

Throughout his career, Matthew has worked with several prominent companies, including Harmony Biosciences, Inc. and Curia Global, Inc. His experience in these organizations has allowed him to refine his expertise in pharmaceutical development and innovation.

Collaborations

Due to space constraints, the collaborations section will be omitted.

Conclusion

Matthew David Surman is a dedicated inventor whose work in pharmaceutical chemistry showcases his commitment to advancing medical treatments. His contributions, particularly in the area of substituted pyridoindoles, highlight the importance of innovation in the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…